Dimethylstilbestrol (DMS) is a nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol which was never marketed. It is a so-called "weak", "impeded", or "short-acting" estrogen similarly to estriol and meso-butoestrol. The affinity of DMS for the ER was reported as about 10% of that of estradiol. For comparison, diethylstilbestrol had 140% of the affinity of estradiol for the ER. The endometrial proliferation dose of DMS in women is 20 mg. A single 12 mg intramuscular injection of DMS has a duration of approximately 12 days in humans.
Property | Value |
---|---|
dbo:abstract |
|
dbo:casNumber |
|
dbo:chEBI |
|
dbo:chEMBL |
|
dbo:class | |
dbo:fdaUniiCode |
|
dbo:kegg |
|
dbo:pubchem |
|
dbo:thumbnail | |
dbo:wikiPageID |
|
dbo:wikiPageLength |
|
dbo:wikiPageRevisionID |
|
dbo:wikiPageWikiLink |
|
dbp:c |
|
dbp:casNumber |
|
dbp:casSupplemental |
|
dbp:chebi |
|
dbp:chembl |
|
dbp:chemspiderid |
|
dbp:class | |
dbp:h |
|
dbp:iupacName |
|
dbp:kegg |
|
dbp:o |
|
dbp:pubchem |
|
dbp:smiles |
|
dbp:stdinchi |
|
dbp:stdinchikey |
|
dbp:synonyms |
|
dbp:unii |
|
dbp:width |
|
dbp:wikiPageUsesTemplate | |
dcterms:subject | |
rdf:type | |
rdfs:comment |
|
rdfs:label |
|
owl:differentFrom | |
owl:sameAs | |
prov:wasDerivedFrom | |
foaf:depiction | |
foaf:isPrimaryTopicOf | |
is dbo:wikiPageDisambiguates of | |
is dbo:wikiPageWikiLink of | |
is owl:differentFrom of | |
is foaf:primaryTopic of |